Allspring Global Investments
LYEL icon

Allspring Global Investments’s Lyell Immunopharma LYEL Stock Holding History

Allspring Global Investments’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-620
Closed -$18.2K – 2518
2023
Q3 		$18.2K Sell
620
-10
-2% -$475 ﹤0.01% 2527
2023
Q2 		$40K Buy
630
+226
+56% +$12.5K ﹤0.01% 2338
2023
Q1 		$19.1K Buy
404
+325
+411% +$17.4K ﹤0.01% 2508
2022
Q4 		$5.47K Sell
79
-699
-90% -$69.4K ﹤0.01% 2776
2022
Q3 		$114K Buy
+778
New +$105K ﹤0.01% 2027

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
WA
WuXi AppTec Shanghai, China $19M AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments's LYEL Position: Q4 2023 in Review

Allspring Global Investments sold out of Lyell Immunopharma (LYEL) in Q4 2023, closing a stake of 620 shares — an estimated $18.2K sold.

Allspring Global Investments first reported a position in LYEL in Q3 2022 and held it in 5 quarters. The position peaked at $114K in Q3 2022. 118 funds tracked by Wall St. Rank hold LYEL as of Q4 2023.

  • Allspring Global Investments reported no remaining Lyell Immunopharma position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 620 Lyell Immunopharma shares in Q4 2023, an estimated $18.2K.
  • Allspring Global Investments first reported a position in Lyell Immunopharma in Q3 2022 and held it in 5 quarters.
  • Allspring Global Investments's Lyell Immunopharma position peaked at $114K in Q3 2022.
  • 118 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.